These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 5796056)

  • 1. Primary aldosteronism: diagnosis and treatment.
    Greenlee HB; Katz FH; Sparagana M
    Surg Clin North Am; 1969 Feb; 49(1):71-85. PubMed ID: 5796056
    [No Abstract]   [Full Text] [Related]  

  • 2. Bilateral adrenal hyperplasia as a cause of primary aldosteronism with hypertension, hypokalemia and suppressed renin activity.
    Davis WW; Newsome HH; Wright LD; Hammond WG; Easton J; Bartter FC
    Am J Med; 1967 Apr; 42(4):642-7. PubMed ID: 6024721
    [No Abstract]   [Full Text] [Related]  

  • 3. Primary aldosteronism: diagnosis, localization, and treatment.
    Weinberger MH; Grim CE; Hollifield JW; Kem DC; Ganguly A; Kramer NJ; Yune HY; Wellman H; Donohue JP
    Ann Intern Med; 1979 Mar; 90(3):386-95. PubMed ID: 218482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on curable hypertension: special reference to renovascular hypertension and primary aldosteronism.
    Oda T
    Jpn Circ J; 1969 Dec; 33(12):1621-6. PubMed ID: 5396206
    [No Abstract]   [Full Text] [Related]  

  • 5. Reliability of screening methods for the diagnosis of primary aldosteronism.
    Streeten DH; Tomycz N; Anderson GH
    Am J Med; 1979 Sep; 67(3):403-13. PubMed ID: 474586
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of corticotropin on aldosterone excretion and plasma renin in normal subjects, in essential hypertension and in primary aldosteronism.
    Newton MA; Laragh JH
    J Clin Endocrinol Metab; 1968 Jul; 28(7):1006-13. PubMed ID: 4298942
    [No Abstract]   [Full Text] [Related]  

  • 7. [Aldosterone excretion and plasma renin activity in patients with essential hypertension and with primary aldosteronism (author's transl)].
    Helber A; Meurer KA; Rosskamp E; Wambach G; Dickmans HA; Kaufmann W
    Klin Wochenschr; 1974 Oct; 52(20):966-73. PubMed ID: 4444216
    [No Abstract]   [Full Text] [Related]  

  • 8. [Secondary hyperaldosteronism].
    Veyrat R; Muller AF; Mach RS
    Schweiz Med Wochenschr; 1968 Jan; 98(3):65-75. PubMed ID: 4299459
    [No Abstract]   [Full Text] [Related]  

  • 9. [Primary aldosteronism without association of hypokalemia].
    Yoshinaga H; Aida M; Miura Y
    Naika; 1969 Oct; 24(4):630-4. PubMed ID: 5358671
    [No Abstract]   [Full Text] [Related]  

  • 10. [Diagnosis and treatment outcome in primary aldosteronism based on a retrospective analysis of 187 cases].
    Szücs N; Gláz E; Varga I; Tóth M; Kiss R; Patócs A; Jakab C; Perner F; Járay J; Horányi J; Dabasi G; Molnár F; Major L; Füto L; Rácz K; Tulassay Z
    Orv Hetil; 2006 Jan; 147(2):51-9. PubMed ID: 16509213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Current problems in primary aldosteronism--4 cases of normokalemic primary aldosteronism (1st degree) caused by adenoma and 3 cases of aldosteronism, 1st degree, caused by hyperplasia (2 hypokalemic cases, a normokalemic case)].
    Oda T
    Naika; 1969 Oct; 24(4):713-24. PubMed ID: 5358678
    [No Abstract]   [Full Text] [Related]  

  • 12. [Primary hyperaldosteronism. A study of 18 cases].
    Cherif L; Ben Abdallah N; Khiari K; Hadj AI; Ben Maïz H; Yahyaoui R; Essaies O; Ktari S; Zidi B
    Tunis Med; 2003 Jul; 81(7):466-76. PubMed ID: 14534957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does prolonged pretreatment with large doses of spironolactone hasten a recovery from juxtaglomerular-adrenal suppression in primary aldosteronism?
    Morimoto S; Takeda R; Murakami M
    J Clin Endocrinol Metab; 1970 Dec; 31(6):659-64. PubMed ID: 4921649
    [No Abstract]   [Full Text] [Related]  

  • 14. Non-tumorous "primary" aldosteronism. I. Type relieved by glucocorticoid (glucocorticoid-remediable aldosteronism).
    Salti IS; Stiefel M; Ruse JL; Laidlaw JC
    Can Med Assoc J; 1969 Jul; 101(1):1-10. PubMed ID: 5793351
    [No Abstract]   [Full Text] [Related]  

  • 15. Panel discussion: the incidence of aldosteronism and early detection in the population.
    Peart WS; Rovner DR; Kaplan NM; Liddle GW
    Am J Clin Pathol; 1970 Sep; 54(3):333-40. PubMed ID: 5507280
    [No Abstract]   [Full Text] [Related]  

  • 16. [Aldosteronism--past, present and future].
    Torikai T
    Nihon Rinsho; 1971 Mar; 29(3):898-903. PubMed ID: 4324172
    [No Abstract]   [Full Text] [Related]  

  • 17. Intravenously administered chlorothiazide in diagnostic evaluation of hypertensive disease.
    McGuffin WL; Gunnells JC
    Arch Intern Med; 1969 Feb; 123(2):124-30. PubMed ID: 5763614
    [No Abstract]   [Full Text] [Related]  

  • 18. Primary aldosteronism. Review of diagnostic tests and 15 cases.
    Koppes G
    J Kans Med Soc; 1972 May; 73(5):259-71 passim. PubMed ID: 5026873
    [No Abstract]   [Full Text] [Related]  

  • 19. Plasma renin activity in the diagnosis of primary aldosteronism: failure to distinguish primary aldosteronism from essential hypertension.
    Jose A; Kaplan NM
    Arch Intern Med; 1969 Feb; 123(2):141-6. PubMed ID: 5812600
    [No Abstract]   [Full Text] [Related]  

  • 20. The dexamethasone-modified adrenal scintiscan in hyporeninemic aldosteronism (tumor versus hyperplasia). A comparison with adrenal venography and adrenal venous aldosterone.
    Conn JW; Cohen EL; Herwig KR
    J Lab Clin Med; 1976 Nov; 88(5):841-56. PubMed ID: 978047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.